FDA Inspection 1056865 — John B. Buse, M.D., Ph.D.
The FDA completed an inspection of John B. Buse, M.D., Ph.D. on Jun 8, 2018 in Chapel Hill, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chapel Hill, NC (United States)
Additional Details
Clinical Investigator (CI)